Of note, we analyzed 41 representative blood samples from the patients in our cohort and observed that all these patients have the same SNP status in their blood as in their tumor (data not shown), indicating that CASP8 SNP D302H is a germline risk factor for NB patients with MYCN amplification. Here, CASP8 is linked to neuroblastoma.